SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies (OPEN) is currently trending due to recent announcements aimed at significantly lowering mortgage rates and boosting the broader housing market. This news has ignited strong community optimism, with many anticipating a substantial increase in transaction volume and a potential short squeeze for the real estate technology stock. Despite ongoing discussions about company fundamentals and potential warrant dilution, a prevailing bullish sentiment suggests a significant upside for OPEN within the revitalized housing sector.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is capturing significant attention following recent industry developments, notably Marvell's acquisition of a key partner and Nvidia's increased emphasis on photonics for advanced AI infrastructure. The community is actively discussing POET's unique optical interposer platform, which promises disruptive advancements in speed, cost, and power efficiency for next-generation data centers, fueling high anticipation for forthcoming commercialization milestones and strategic orders.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

The controversial ICE agent-involved shooting in Minneapolis is a dominant discussion point for $DJT, with community members sharply divided over the justification of force and characterizing the event as either murder or a necessary act of self-defense. Amidst this, users are also actively debating recent statements from Donald Trump regarding potential housing market interventions, including instructing representatives to consider buying $200 billion in mortgage bonds and restricting institutional homeownership, with some critics drawing comparisons to "democratic socialist" policies.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is generating significant community buzz, primarily driven by strong anticipation for a multi-billion dollar NASA Lunar Terrain Vehicle (LTV) contract award. Investors are also noting a recently identified federal contract with NASA and the strategic Lanternis acquisition, positioning LUNR as a key player in the expanding aerospace and defense sector. This widespread bullish sentiment is fueled by expectations of a substantial price surge upon the LTV announcement, with many observing increased short activity.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is currently facing heightened market uncertainty, as investors closely monitor the anticipated Supreme Court ruling on tariffs and upcoming economic data, including the jobs report. Community sentiment is sharply divided, with some anticipating new highs while others express concern about Nasdaq losing momentum and potential market manipulation amidst broader geopolitical and political policy shifts.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor is trending due to robust year-over-year growth in its latest sales report and escalating demand for AI chips, prompting major investment banks to raise price targets. The community is actively discussing TSM's critical role as the global "backbone" for advanced AI semiconductor manufacturing. This strong position is further underscored by reports that NVIDIA is seeking increased H200 production, despite ongoing geopolitical considerations regarding Taiwan.

Polygon

Polygon is actively trending amid significant discussion surrounding its utility and institutional adoption, with reports of BlackRock investments and J.P. Morgan leveraging its DeFi capabilities, alongside integrations with platforms like Instagram. The community is eagerly debating a potential return to the familiar MATIC ticker, balancing Polygon's ongoing technical advancements as a leading Ethereum Layer 2 solution with strong brand recognition. This confluence of major partnerships and an internal brand identity discussion is fueling widespread conversation.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending following disappointing FY2026/2027 revenue guidance for its key drug, DefenCath, amidst the anticipated expiration of a crucial reimbursement mechanism, triggering widespread community frustration and a significant stock sell-off. While management highlights portfolio diversification and pipeline catalysts, investors are intensely debating the stock's valuation and the potential impact of pending legislation aimed at improving kidney care payment systems.

Pippin is an SVG unicorn drawn using the latest LLM benchmarks on ChatGPT 4o. It is an autonomous AI agent on X. Pippin was created by Yohei Nakajima, a recognised innovator and thought leader in the Al VC space (followed by Jeff Bezos and Marc Andreessen). He is known for his build-in-public approach and has been at the forefront of the ‘AI for VC’ movement, launching over 100+ AI-driven prototypes, automation agents &amp; open-source projects.  His most notable build is BabyAGI (March 2023), the first popular open-source autonomous agent with task-planning capability. The project went viral on Twitter amassing millions of impressions and resulting in tens of thousands of GitHub stars, dozens of Arxiv citations, coverage across major online media publications globally, and many speaker engagements including the inaugural TED AI in San Francisco.

pippin

PIPPIN CRYPTO is trending due to significant price surges, reportedly fueled by short squeezes and recent exchange listings for this Solana-based, AI-driven project. Community sentiment is sharply divided, with many celebrating its strong performance and resilience, while a vocal segment warns of it being a potential scam, citing concerns over concentrated whale holdings and manipulated volume.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Allogene's Q1 Earnings In Line With Estimates, Sales Nil

Elevation Oncology downgraded as it halts lead asset on disappointing trials

Investing.com -- Wall Street cut rating on  Elevation Oncology  Inc (NASDAQ:ELEV) after the company announced it will discontinue development of its lead asset, EO-3021, due to disappointing efficacy in a Phase 1 trial. Analysts now see limited near-term catalysts, with Elevation pivoting to its HER3-targeted ADC, EO-1022, which is still in preclinical development.

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.

Elevation Oncology Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

ELEV
Elevation Oncology Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest ELEV News

ELEVElevation Oncology Inc